Somnomed Ltd has released a press release.
FDA 510k approval for SomnoDent Alpha
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Somnomed
- Strong finish to the financial year for SomnoMed
- Derek Smith appointed Global CEO of SomnoMed
- Results of Institutional Entitlement Offer
- Chairmans Letter
- Continuing High Growth in the Third Quarter
Later from Somnomed
- Sales growth accelerating
- Renew Sleep Solutions opens first two centres in Q2
- Renew Sleep Solutions well ahead of plan
- Strong Q4 growth to finish transitional year
- Good revenue growth for the quarter
Follow Somnomed into a list and get an email when it puts out news.
Follow Somnomed